학술논문
The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis.
Document Type
Article
Author
Source
Subject
*MYELODYSPLASTIC syndromes
*ETHNICITY
*ACUTE myeloid leukemia
*OVERALL survival
*SURVIVAL rate
*
*
*
*
Language
ISSN
1042-8194
Abstract
Race and ethnic backgrounds affect the disease characteristics and clinical outcomes in many cancers, including acute myeloid leukemia; however, the association of race/ethnicity on myelodysplastic syndrome (MDS) is still controversial. Therefore, we aimed to study the impact of race/ethnicity on the disease characteristics and survival outcomes in patients with MDS. Adult patients with MDS diagnosed in 2004–2016 were selected using the SEER database. Race/ethnicity was categorized as non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic. Hispanic and NHB patients had significantly lower incidence rate ratio (IRR) in age group ≥01 years (p <.001) compared to NHW; however, in the age group <50 years, NHB patients had significantly higher IRR with an increased incidence rate of 49%. NHB patients had better overall survival than Hispanic and NHW patients (p <.001), even after adjusting for confounding variables. MDS have significant differences in age at diagnosis, disease risk, and survival outcomes based on racial/ethnic backgrounds. [ABSTRACT FROM AUTHOR]